Hypofibrinogenemia associated with a heterozygous missense mutation γ153Cys to Arg (Matsumoto IV): In vitro expression demonstrates defective secretion of the variant fibrinogen

Blood

Volumn 94, Issue 12, 1999, Pages 4122-4131

  Terasawa, Fumiko ^b   Okumura, Nobuo ^a   Kitano, Kiyoshi ^b   Hayashida, Nobuaki ^b   Shimosaka, Makoto ^b   Okazaki, Mitsuo ^b   Lord, Susan T ^b  

^a SHINSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYSTEINE; FIBRINOGEN;

ADULT; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CASE REPORT; CHO CELL; CONTROLLED STUDY; FEMALE; FIBRINOGEN DEFECT; FIBRINOGEN SYNTHESIS; HETEROZYGOSITY; HUMAN; HUMAN CELL; HYPOFIBRINOGENEMIA; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0032787011     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.12.4122     Document Type: Article

References (36)

1. Doolittle RF, Bouma IH, Cottrell BA, Strong D, Watt KWK: The covalent structure of human fibrinogen, in Bing DH (ed): The Chemistry and Physiology of the Human Plasma Proteins, New York, NY, Pergamon, 1979, p 77
2. Doolittle RF: Fibrinogen and fibrin. Sci Am 245:92, 1981
3. Imperato C, Dettori A: Ipofibrinogenemia congenital con fibrinoastenia. Helv Paed Acta 13:380, 1958
4. Koopman J, Haverkate F: Hereditary variants of human fibrinogens, in Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (eds): Haemostasis and Thrombosis (ed 3). Edinburgh, UK, Churchill Livingstone, 1994, p 515
5. Ebert RF: Index of Variant Human Fibrinogens, 1994 Edition, Boca Raton, FL, CRC, 1994
6. Robe F, Salomon E: Uber Faserstoffmangel in Blut bei einen Falle von Haemophilie. Dtsch Arck Klin Med 132:240, 1920
7. Mammen EF: Fibrinogen abnormalities. Semin Thromb Hemost 9:1, 1983
8. Risak E: Fibrinopenie. A Klin Med 128:605, 1935
9. Roberts HR, Eberst ME: Disorders of fibrinogen, in Loscalzo J, Schafer AI (eds): Thrombosis and Hemorrhage. Boston, MA, Blackwell Scientific, 1994, p 701
10. Reitsma PH, Beraardi F, Doig RG, Gandrille S, Greengard JS, Ireland H, Krawczak M, Lind B, Long GL, Poort SR, Saito H, Sala N, Witt I, Cooper DN: Protein C deficiency: A data base of mutations, 1995 update. Thromb Haemost 73:876, 1995
11. Gandrille S, Borgel D, Eschwege-Gufflet V, Aillaud MF, Dreyfus M, Matheron C, Gaussem P, Abgrall JF, Jude B, Sie P, Toulon P, Aiach M: Identification of 15 different candidate causal point mutations and three polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active gene. Blood 85:130, 1995
12. Lane DA, Olds RJ, Boisclair M, Chowdhury V, Thein SL, Cooper DN, Blajchman M, Perry D, Emmerich J, Aiach M: Antithrombin III mutation database: First update. Thromb Haemost 70:361, 1993
13. Tuddenham EGD, Pemberton S, Cooper DN: Inherited factor VII deficiency: Genetics and molecular pathology. Thromb Haemost 74:313, 1995
14. Sugahara Y, Miura O, Hirosawa S, Aoki N: Compound heterozygous protein C deficiency caused by two mutations, Arg-178 to Gln and Cys-331 to Arg, leading to impaired secretion of mutant protein C. Thromb Haemost 72:814, 1994
15. Ozawa T, Takikawa Y, Niiya K, Fujiwara T, Suzuki K, Sato S, Sakuragawa N: Antithrombin Morioka (Cys 95-Arg): A novel missense mutation causing type I antithrombin deficiency. Thromb Haemost 77:403, 1997
16. Ridgway HJ, Brennan SO, Faed JM, George PE: Fibrinogen Otago: A major a chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage. Br J Haematol 98:632, 1997
17. Ridgway HJ, Brennan SO, Gibbons S, George PE: Fibrinogen Lincoln: A new truncated a chain variant with severe delayed clotting. Br J Haematol 93:177, 1996
18. Koopman J, Haverkate F, Grimbergen J, Egbring R, Lord ST: Fibrinogen Marburg: A homozygous case of dysfibrinogenemia, lacking amino acids Aα 461-610 (Lys 461 AAA → Stop TAA). Blood 80:1972, 1992
19. Furlan M, Steinmann C, Jungo M, Bögli C, Baudo F, Redaelli R, Fedeli F, Lämmle B: A frameshift mutation in exon V of the Aα-chain gene leading to truncated Aα-chains in the homozygous dysfibrinogen Milano III. J Biol Chem 269:33129, 1994
20. Neerman-Arbez M, Honsberger A, Antonarakis SE, Morris MA: Deletion of the alpha-chain gene (FGA) causes congenital afibrinogenemia. J Clin Invest 103:215, 1999
21. George P, Wyatt J, Callea F, Brennan S: Fibrinogen Brescia: Hypofibrinogenemia and hepatic fibrinogen storage are associated with a gamma chain substitution (284 Gly to Arg) and hypersialylation of the circulating fibrinogen. Blood Coagul Fibrinolysis 9:698, 1998 (abstr)
22. Okumura N, Furihata K, Terasawa F, Nakagoshi R, Ueno I, Katsuyama T: Fibrinogen Matsumoto I: A γ364Asp→His(GAT→CAT) substitution associated with defective fibrin polymerization. Thromb Haemost 75:887, 1996
23. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
24. Gustafson S, Proper JA, Bowie EJW, Sommer SS: Parameters affecting the yield of DNA from human blood. Anal Biochem 165:294, 1987
25. Rooney MM, Parise LV, Lord ST: Dissecting clot retraction and platelet aggregation. Clot retraction does not require an intact fibrinogen γ chain C terminus. J Biol Chem 271:8553, 1996
26. Okumura N, Gorkun OV, Lord ST: Severely impaired polymerization of recombinant fibrinogen γ-364 Asp→ His, the substitution discovered in a heterozygous individual. J Biol Chem 272:29596, 1997
27. Binnie CG, Hettasch JM, Strickland E, Lord ST: Characterization of purified recombinant fibrinogen: Partial phosphorylation of fibrinopeptide A. Biochemistry 32:107, 1993
28. Kingston RE, Chen CA, Okayama H: Transfection of DNA into eukaryotic cells Calcium phosphate transfection, in Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds): Current Protocols in Molecular Biology. New York, NY, Wiley, 1989, p 9.1.1
29. Murano G, Wiman B, Blombäck M, Blombäck B: Preparation and isolation of the S-carboxymethyl derivative chains of human fibrinogen. FEBS Lett 14:37, 1971
30. Yamamoto K, Tanimoto M, Emi N, Matsushita T, Takamatsu J, Saito H: Impaired secretion of the elongated mutant of protein C (protein C-Nagoya): Molecular and cellular basis for hereditary protein C deficiency. J Clin Invest 90:2439, 1992
31. Chung DW, Harris JE, Davie EW: Nucleotide sequences of the three genes coding for human fibrinogen, in Lie CY, Chien S (eds): Fibrinogen, Thrombosis, Coagulation and Fibrinolysis. New York, NY, Plenum, 1990, p 39
32. Baumann RE, Henschen AH: Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: Identification of polymorphisms at positions Aα312 and Bβ448. Blood 82: 2117, 1993
33. Spraggon G, Everse SJ, Doolittle RF: Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 389:455, 1997
34. Yee VC, Pratt KP, Côté HCF, Le Trong I, Chung DW, Davie EW, Stenkamp RE, Teller DC: Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen. Structure 5:125, 1997
35. Liu CY, Koehn JA, Morgan FJ: Characterization of fibrinogen New York 1 A dysfunctional fibrinogen with a deletion of Bβ(9-72) corresponding exactly to exon 2 of the gene. J Biol Chem 260:4390, 1985
36. Huang S, Mulvihill ER, Farrell DH, Chung DW, Davie EW: Biosynthesis of human fibrinogen. Subunit interactions and potential intermediates in the assembly. J Biol Chem 268:8919, 1993